
Chen's Laboratory
At the University of Utah, our laboratory is dedicated to studying and conducting research at the intersection of immunology and the engineering of biological therapeutics including peptides, proteins, and cells. We possess a deep-rooted passion for exploring the mysteries of immunity and investigating various immunological disorders, including autoimmune diseases and cancer, among others. Our ultimate aim is to develop effective treatments and ultimately find cures for individuals affected by these conditions.
In pursuit of this goal, we are constantly engaged in the creation of novel peptides, proteins, engineered cells that hold potential as innovative medicines or as essential components of new formulations and tools for advancing medical treatments. Meanwhile, we are actively involved in the invention and refinement of cutting-edge engineering approaches, such as CRISPR, omics-guided target identification, and artificial intelligence-enhanced protein and antibody designs.
We wholeheartedly welcome collaborations from those who share our passion and interests. If you are equally passionate about these areas of research, we encourage you to reach out and explore opportunities for collaboration. Together, we can make significant strides in advancing our understanding of immunology and developing transformative therapies for those in need.
Our laboratory is hosted in the state-to-art L.S. Skaggs Research Institute and supported by the Department of Molecular Pharmaceutics at the University of Utah as well as extramural fundings.
Open Positions: Our lab is continuously accepting applications for Postdoctoral Associate and PhD student positions.
News
March 18, 2025: Congratulations to Professor Shuyun. Her cell engineering project received a SEED grant support from the University of Utah Office of The Vice President for Research and College of Pharmacy.

February 28, 2025: Tianxiao Zhange received the Best Poster Award at 19th International Symposium on Recent Advances in Drug Delivery Systems in Salt Lake City, Utah. His poster title is “Recombinant Anti-PD-1 Immunotoxin (PD-1 DIT) for Autoimmune Disease Treatment”. Received. The award is conferred by Elsevier Publisher and Journal of Nanobiotechnology.
December 8th, 2024: Dr. Chen and his collaborator, Dr. Cameron Metcalf were recognized by the Cure Epilepsy organization for the CURE Epilepsy Award at the American Epilepsy Society annual meeting in Los Angeles.